Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

References

• Olsson R, Remberger M, Schaffer M, et al. Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transplant 2013;48:537–543.
   PubMed Web of Science ®Google Scholar
• Mattson J, Ringdén O, Storb R. Graft-failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008;14:165–170.
   Web of Science ®Google Scholar
• Passweg JR, Zhang MJ, Rocha V, et al. Donor characteristics affecting graft-failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. Biol Blood Marrow Transplant 2011;17:1855–1877.
   PubMed Web of Science ®Google Scholar
• Anasetti C, Logan BR, Lee SJ, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 2012;367:1487–1496.
   PubMed Web of Science ®Google Scholar
• Wolff SN. Second hematopoietic stem cell transplantation for the treatment of graft-failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002;29:545–552.
   PubMed Web of Science ®Google Scholar
• Guardiola P, Kuentz M, Garban F, et al. French Society of Bone Marrow Transplantation. Second early allogeneic stem cell transplantations for graft failure in acute leukemia, chronic myeloid leukemia and aplastic anemia. Br J Haematol 2000;111:292–302.
   PubMed Web of Science ®Google Scholar
• Waki F, Masuoka K, Fukuda T, et al. Feasibility of reduced-intensity cord blood transplantation as a salvage therapy for graft failure: results of nationwide survey of 80 adult patients. Biol Blood Marrow Transplant 2011;17:841–851.
   PubMed Web of Science ®Google Scholar
• Schriber J, Agovi MA, Ho V, et al. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant 2010;16:1099–1106.
   PubMed Web of Science ®Google Scholar
• Fuji S, Nakamura F, Hatanaka K, et al. Peripheral blood as preferable source of stem cell transplantation in patients with graft-failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hepatopoietic Cell Transplantation. Biol Blood Marrow Transplant 2012;18:1407–1414.
   PubMed Web of Science ®Google Scholar
• Rondon G, Saliba RM, Khouri I, et al. Long-term follow-up of patients who experienced graft failure post allogeneic progenitor cell transplantation. Results of a single institution analysis. Biol Blood Marrow Transplant 2008;14:859–866.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Ballen K, Rizzo JD, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009;15:1628–1633.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995:15:825–828.
   PubMed Web of Science ®Google Scholar
• Sullivan KM, Agura E, Anesetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991;28:250–259.
   PubMed Web of Science ®Google Scholar
• Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant 1990;5:69–82.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
   Web of Science ®Google Scholar
• Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competiting risk. Ann Stati 1988;16:1141–1154.
   Web of Science ®Google Scholar
• Stelljes M, van Biezen A, Slavin S, et al. Complications Subcommittee of the Chronic Leukemia Working Party. The harvest an use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2008;42:739–742.
   PubMed Web of Science ®Google Scholar
• Pottinger B, Walker M, Campbell M, et al. The storage and re-infusion of autologous blood and BM as back-up following failed primary hematopoietic stem-cell transplantation: a survey of European practice. Cytotherapy 2002;4:127–135.
   PubMed Web of Science ®Google Scholar
• Byrne BJ, Horwitz M, Long GD, et al. Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. Bone Marrow Transplant 2008;41:39–43.
   PubMed Web of Science ®Google Scholar
• Fernandes J, Rocha V, Robin M, et al. Second transplant with two unrelated cord blood units for early graft-failure after hematopoietic stem cell transplantation. Br J Haematol 2007;137:248–250.
   PubMed Web of Science ®Google Scholar
• Remberger M, Mattson J, Olsson R, et al. Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure. Clin Transplant 2011;25:E68–E76.
   Google Scholar
• Platzbecker U, Binder M, Schmid C, et al. Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft-failure after allogeneic transplantation. Haematologica 2008;93:1276–1278.
   PubMed Web of Science ®Google Scholar
• Heinzelmann F, Lang PJ, Ottinger H, et al. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. Int J Radiat Oncol Biol Physi2008;70:523–528.
   PubMed Web of Science ®Google Scholar
• Chewning JH, Castro-Malaspina H, Jakubowski A, et al. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biol Blood Marrow Transplant 2007;13:1313–1323.
   PubMed Web of Science ®Google Scholar
• Gyurkocza B, Cao TM, Storb R, et al. Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. Biol Blood Marrow Transplant 2009;15:1314–1322.
   PubMed Web of Science ®Google Scholar
• Sumi M, Shimizu I, Sato K, et al. Graft-failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation. Int J Hematol 2010;92:744–750.
   PubMed Web of Science ®Google Scholar
• Jabbour E, Rondon G, Anderlini P, et al. Treatment of donor graft failure with non-myeloablative conditioning of fludarabine, anti-thymocyte globulin and a second allogeneic hematopoietic transplantation. Bone Marrow Transplant 2007;40:431–435.
   PubMed Web of Science ®Google Scholar
• Moscardó F, Sanz J, Senent L, et al. Impact of hematopoietic chimerism at day + 14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies. Haematologica 2009;94:827–832.
   PubMed Web of Science ®Google Scholar
• Cutler C, Kim HT, Sun L, et al. Donor specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood 2011;118:6691–6697.
   PubMed Web of Science ®Google Scholar
• Ciurea SO, Thall PF, Wang X, et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood 2011;118:5957–5964.
   PubMed Web of Science ®Google Scholar